[1] 中华医学会风湿病学分会. 骨关节炎诊断及治疗指南 [J]. 中华风湿病学杂志,2010,14(6)CHINESE JOURNAL OF RHEUMATOLOGY,2010,14(6)
[2] Sharma L. Osteoarthritis year in review 2015: clinical[J]. Osteoarthritis Cartilage, 2016,24(1):36-48. DOI: 10.1016/j.joca.2015.07.026.
[3] Pereira D, Peleteiro B, Araújo J, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review[J]. Osteoarthritis Cartilage, 2011,19(11):1270-1285. DOI: 10.1016/j.joca.2011.08.009.
[4] Bruyère O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)[J]. Semin Arthritis Rheum, 2014,44(3):253-263. DOI: 10.1016/j.semarthrit.2014.05.014.
[5] Fernandes L, Hagen KB, Bijlsma JW, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis[J]. Ann Rheum Dis, 2013,72(7):1125-1135. DOI: 10.1136/annrheumdis-2012-202745.
[6] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊治指南 (2011 年)[J]. 中华骨质疏松和骨矿盐疾病杂志,2011,04(1)CHINESE JOURNAL OF OSTEOPOROSIS AND BONE MINERAL RESEARCH,2011,04(1)
[7] 沈海丽, 夏亚一, 王翠芳, 等. 骨关节炎的疼痛机制研究进展 [J]. 中华风湿病学杂志,2010,14(11)CHINESE JOURNAL OF RHEUMATOLOGY,2010,14(11)
[8] Hardy MM, Seibert K, Manning PT, et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants[J]. Arthritis Rheum, 2002,46(7):1789-1803. DOI: 10.1002/art.10356.
[9] de Boer TN, Huisman AM, Polak AA, et al. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment[J]. Osteoarthritis Cartilage, 2009,17(4):482-488. DOI: 10.1016/j.joca.2008.09.002.
[10] Jevsevar DS, Brown GA, Jones DL, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition[J]. J Bone Joint Surg Am, 2013,95(20):1885-1886.
[11] Imamura M, Imamura ST, Kaziyama HH, et al. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis[J]. Arthritis Rheum, 2008,59(10):1424-1431. DOI: 10.1002/art.24120.
[12] Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials[J]. Lancet, 2013,382(9894):769-779. DOI: 10.1016/S0140-6736(13)60900-9.
[13] Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review[J]. Br J Sports Med, 2015,49(24):1554-1557. DOI: 10.1136/bjsports-2015-095424.
[14] Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2007,66(4):433-439. DOI: 10.1136/ard.2006.065904.
[15] Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest[J]. Arthritis Rheum, 2007,56(7):2105-2110. DOI: 10.1002/art.22852.
[16] Bjordal JM, Klovning A, Ljunggren AE, et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials[J]. Eur J Pain, 2007,11(2):125-138. DOI: 10.1016/j.ejpain.2006.02.013.
[17] Pavelká K, Gatterová J, Olejarová M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study[J]. Arch Intern Med, 2002,162(18):2113-2123.
[18] Kahan A, Uebelhart D, De Vathaire F, et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial[J]. Arthritis Rheum, 2009,60(2):524-533. DOI: 10.1002/art.24255.
[19] Railhac JJ, Zaim M, Saurel AS, et al. Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI[J]. Clin Rheumatol, 2012,31(9):1347-1357. DOI: 10.1007/s10067-012-2022-4.
[20] Gallagher B, Tjoumakaris FP, Harwood MI, et al. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents[J]. Am J Sports Med, 2015,43(3):734-744. DOI: 10.1177/0363546514533777.
[21] Fransen M, Agaliotis M, Nairn L, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens[J]. Ann Rheum Dis, 2015,74(5):851-858. DOI: 10.1136/annrheumdis-2013-203954.
[22] Zeng C, Wei J, Li H, et al. Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee[J]. Sci Rep, 2015,5:16827. DOI: 10.1038/srep16827
[23] Raynauld JP, Pelletier JP, Abram F, et al. Long-term effects of glucosamine/chondroitin sulfate on the progression of structural changes in knee osteoarthritis: 6-year follow-up data from the osteoarthritis initiative[J]. Arthritis Care Res (Hoboken), 2016,DOI: 10.1002/acr.22866.
[24] Bertin P, Taieb C. NSAID-sparing effect of glucosamine hydrochloride in patients with knee osteoarthritis: an analysis of data from a French database[J]. Curr Med Res Opin, 2014,30(2):271-277. DOI: 10.1185/03007995.2013.855184.
[25] Rovati LC, Girolami F, D'Amato M, et al. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study[J]. Semin Arthritis Rheum, 2016,45(4 Suppl):S34-41. DOI: 10.1016/j.semarthrit.2015.10.009.
[26] Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes[J]. Curr Med Res Opin, 2016:1-8. DOI: 10.1185/03007995.2016.1154521.
[27] 邱贵兴, 翁习生, 张克, 等. 盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究 [J]. 中华医学杂志,2005,85(43)QIU, Gui-xing, WENG, et al.A multi-central,randomized, controlled clinical trial of glucosamine hydrochloride / sulfate in the treatment of knee osteoarthritis[J].NATIONAL MEDICAL JOURNAL OF CHINA,2005,85(43)
[28] Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis[J]. N Engl J Med, 2006,354(8):795-808. DOI: 10.1056/NEJMoa052771.
[29] Hochberg MC, Martel-Pelletier J, Monfort J, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib[J]. Ann Rheum Dis, 2016,75(1):37-44. DOI: 10.1136/annrheumdis-2014-206792.
[30] Gilzad-Kohan MH, Jamali F. Glucosamine and adjuvant arthritis: a pharmacokinetic and pharmacodynamic study[J]. Eur J Pharm Sci, 2012,47(2):387-393. DOI: 10.1016/j.ejps.2012.06.003.
[31] 蔺超, 黄朝梁, 常蕾, 等. 盐酸氨基葡萄糖及其与甲氨蝶呤联用对佐剂性关节炎大鼠的治疗作用 [J]. 中国生物制品学杂志,2009,22(2)Curative Effect of Glucosamine Hydrochloride Administered Alone or Com-bined with Methotrexate on Rat Model of Adjuvant Arthritis[J].CHINESE JOURNAL OF BIOLOGICALS,2009,22(2)
[32] 余文景, 梁翼, 李敏等. 盐酸氨基葡萄糖胶囊对类风湿关节炎致膝关节软骨损伤的临床观察 [J]. 四川医学,2013,34(12):1809-1812.
[33] 张迪生, 王积忠. 氨基葡萄糖逆转儿童类风湿关节炎畸变及相关机制探讨 [J]. 安徽医学,2012,33(1):46-49.DOI:10.3969/j.issn.1000-0399.2012.01.018.
[34] Christensen R, Bartels EM, Astrup A, et al. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials[J]. Osteoarthritis Cartilage, 2008,16(4):399-408. DOI: 10.1016/j.joca.2007.10.003.
[35] Bartels EM, Bliddal H, Schøndorff PK, et al. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials[J]. Osteoarthritis Cartilage, 2010,18(3):289-296. DOI: 10.1016/j.joca.2009.10.006.
评论